Trilogy Capital Inc. Reduces Holdings in Amgen Inc. (NASDAQ:AMGN)

Trilogy Capital Inc. trimmed its holdings in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 2.0% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 10,042 shares of the medical research company’s stock after selling 207 shares during the quarter. Trilogy Capital Inc.’s […]

Leave a Reply

Your email address will not be published.

Previous post Lido wstETH 24-Hour Volume Hits $30.57 Million (WSTETH)
Next post McElhenny Sheffield Capital Management LLC Has $649,000 Holdings in Chevron Co. (NYSE:CVX)